Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how much of the study drug SSP-004184 (SPD602) is
absorbed by the body and how long it takes to be eliminated from the body in healthy subjects
and subjects with mild, moderate, and severe hepatic (liver) impairment compared with
subjects with healthy normal liver function.